Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab beta
Richa Jain(Post Graduate Institute of Medical Education and Research), Deepak Bansal(Post Graduate Institute of Medical Education and Research), Akshay Kumar Saxena(Post Graduate Institute of Medical Education and Research), Amita Trehan(Institute for Postgraduate Medical Education), Bhagwant Rai Mittal(Government of Haryana), Rakesh Kapoor(Post Graduate Institute of Medical Education and Research), Prema Menon(Post Graduate Institute of Medical Education and Research), Radhika Srinivasan(Galgotias University), Nandita Kakkar, Ram Samujh(Post Graduate Institute of Medical Education and Research), Neelam Varma(Nagpur Institute of Technology)
Cited by 11
Related Papers
X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene
|The American Journal of Human Genetics|1999|264
Non‐cirrhotic portal fibrosis (idiopathic portal hypertension): Experience with 151 patients and a review of the literature
|Journal of Gastroenterology and Hepatology|2002|233
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
|Gynecologic Oncology|2019|121
Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis – Case report and systematic review
|Journal of Infection|2008|114
Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients
|Asian Journal of Transfusion Science|2014|106